We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

85 hedge funds and large institutions have $4.75M invested in VistaGen Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $4K | Put options by funds: $2K

0.25% less ownership

Funds ownership: 0.91% → 0.66% (-0.25%)

8% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 25

8% less funds holding

Funds holding: 92 → 85 (-7)

41% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 17

48% less capital invested

Capital invested by funds: $9.13M → $4.75M (-$4.39M)

Holders
85
Holders Change
-7
Holders Change %
-7.61%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
25
Closed
17
Calls
$4K
Puts
$2K
Net Calls
+$2K
Net Calls Change
-$401K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$71.9K
2
State Street
State Street
Massachusetts
+$66.6K
3
Northern Trust
Northern Trust
Illinois
+$30.9K
4
GWSG
GPS Wealth Strategies Group
Colorado
+$30.9K
5
UBS Group
UBS Group
Switzerland
+$22.9K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$1.38M
2
Renaissance Technologies
Renaissance Technologies
New York
-$459K
3
MCM
MAI Capital Management
Ohio
-$155K
4
Millennium Management
Millennium Management
New York
-$93.7K
5
Simplex Trading
Simplex Trading
Illinois
-$52.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AWS
76
Atria Wealth Solutions
New York
$1.03K – – –
DWM
77
Drive Wealth Management
Utah
$1.03K – – –
Commonwealth Equity Services
78
Commonwealth Equity Services
Massachusetts
$1K -$1.25K -333 -34%
Carson Wealth (CWM LLC)
79
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
Mariner
80
Mariner
Kansas
$1K – – –
Belvedere Trading
81
Belvedere Trading
Illinois
$511 +$621 +165 New
Citigroup
82
Citigroup
New York
$161 -$177 -47 -47%
EI
83
Ellevest Inc
New York
$33 +$41 +11 New
CS
84
Credit Suisse
Switzerland
$1 -$286 -76 Closed
Franklin Resources
85
Franklin Resources
California
– -$1.38M -303,218 Closed
CM
86
Caption Management
Oklahoma
– -$50K -10,972 Closed
VF
87
Virtu Financial
New York
– -$35K -7,691 Closed
Acadian Asset Management
88
Acadian Asset Management
Massachusetts
– -$28K -6,214 Closed
CAPTRUST Financial Advisors
89
CAPTRUST Financial Advisors
North Carolina
– -$16K -3,500 Closed
Jane Street
90
Jane Street
New York
– -$10K -2,272 Closed
Neuberger Berman Group
91
Neuberger Berman Group
New York
– -$9K -1,887 Closed
MGIA
92
Moneta Group Investment Advisors
Missouri
– -$8K -1,753 Closed
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$6.92K -1,516 Closed
HFS
94
Hantz Financial Services
Michigan
– -$4K -867 Closed
FIA
95
FNY Investment Advisers
New York
– -$3.01K -800 -91%
Ameriprise
96
Ameriprise
Minnesota
– -$3K -726 Closed
PHK
97
Point72 Hong Kong
Hong Kong
– -$3K -569 Closed
JWM
98
Jackson Wealth Management
Florida
– -$3K -558 Closed
NAS
99
Nicolet Advisory Services
Wisconsin
– -$1K -333 Closed
SWM
100
Selective Wealth Management
Virginia
– -$1K -117 Closed
1 2 3
4
5

VTGN Hedge Fund Activity: Q4 2022 in Review

85 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q4 2022, worth a combined $4.75M — down 48% from $9.13M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of VTGN and 10 opened new positions — a net loss of 7 holders — while 25 trimmed existing stakes and 23 added.

The largest buyer was BlackRock, adding an estimated $71.9K. The largest seller was Franklin Resources, exiting entirely with an estimated $1.38M sold.

  • 85 institutional investors held VistaGen Therapeutics (VTGN) as of Q4 2022, down from 92 in Q3 2022.
  • Funds reported $4.75M of VistaGen Therapeutics stock for Q4 2022, down 48% quarter-over-quarter.
  • 10 funds opened new VistaGen Therapeutics positions in Q4 2022 and 17 closed out, a net change of -7 holders.
  • The largest VistaGen Therapeutics buyer in Q4 2022 was BlackRock, an estimated $71.9K added.
  • The largest VistaGen Therapeutics seller in Q4 2022 was Franklin Resources, an estimated $1.38M sold.

Based on aggregated 13F filings for Q4 2022.